Victory RS Small Cap Growth Y holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Victory RS Small Cap Growth Fund Class Y RSYEX
- NAV / 1-Day Return $72.52 / −1.63 %
- Fund Size $336.0M
- Adjusted Expense Ratio 1.130%
- Net Expense Ratio 1.130%
- Fee Level: Distribution High
- Share Class Type Institutional
- Morningstar Category Small Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $1M
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 95%
Morningstar’s Analysis RSYEX
Will RSYEX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Guardant Health Inc | 2.70 | 9M | Healthcare |
Mercury Systems Inc | 2.32 | 8M | Industrials |
Adaptive Biotechnologies Corp | 2.23 | 8M | Healthcare |
MSC Industrial Direct Co Inc Class A | 2.09 | 7M | Industrials |
Semtech Corp | 2.05 | 7M | Technology |
FirstCash Holdings Inc | 1.95 | 7M | Financial Services |
Riot Platforms Inc | 1.94 | 7M | Financial Services |
Spyre Therapeutics Inc | 1.86 | 6M | Healthcare |
Halozyme Therapeutics Inc | 1.77 | 6M | Healthcare |
JFrog Ltd Ordinary Shares | 1.74 | 6M | Technology |